Par Drugs and Chemicals Limited — Board Meeting, 11-01-2025: Outcome of Board Meeting

The Board of Directors has held a meeting and made several key decisions. They approved the slump sale of the existing establishment for ₹95 crore, with completion expected between September and December 2025, subject to shareholder approval. The board also decided to enter the clean energy, real estate, and capital markets by altering the Memorandum of Association. Additionally, they will convene an Extraordinary General Meeting on February 12, 2025. The board noted the resignations of Mr. Ghanshyambhai Savani as Whole Time Director and Mrs. Nayna Savani as Non-Executive Director, with new committee appointments made accordingly.